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Abstract
Introduction: Systemic lupus erythematosus is a disease which may initially present with varying symptoms, most
commonly a photosensitive rash and arthritis. Protein losing enteropathy is a recognized but rare presenting
manifestation. Diagnosing protein losing enteropathy in resource limited centres is challenging but possible
through the exclusion of other possible causes of hypoalbunaemia.
Case Presentation: We report a case of protein losing gastroenteropathy secondary to intestinal lymphangiectasia
as the initial manifestation of systemic lupus erythematosus in a 57 year old Sri Lankan (South Asian) male patient.
The diagnosis was made by the exclusion of other causes of hypoalbuminaemia as the gold standard
investigations for protein losing enteropathy were not available at this centre.
Conclusions: Protein losing enteropathy is a diagnosis of exclusion in resource limited centres in the world.
Systemic lupus erythematosus should be considered in the differential diagnosis of protein losing enteropathy.
Intestinal lymphangiectasia should also be recognized as a possible pathophysiological mechanism.
Introduction
Protein-losing enteropathy (PLE) is a condition charac-
terized by hypoalbuminaemia secondary to excessive
loss of serum protein from the gastrointestinal tract.
Possible mechanisms of intestinal protein loss include
partial lymphatic obstruction (intestinal lymphangiecta-
sia), congenital defects in intestinal lymphatics, mucosal
ulceration, disordered mucosal cell metabolism and
increased central venous pressure [1].
PLE is a well recognized but unusual manifestation of
systemic lupus erythematosus (SLE) [2,3]. It could rarely
be the initial manifestation of the disease [4]. The exact
pathogenesis of PLE in SLE remains uncertain. Intestinal
or mesenteric vasculitis is a possible mechanism [5] but
is rarely found in mucosal biopsies. Other hypothesized
mechanisms include intestinal lymphangiectasia, muco-
sal disruption and increased mucosal capillary perme-
ability due to complement- or cytokine-mediated
damage [6,7]
Case Presentation
A 56-year-old Sri Lankan male patient presented an year
ago, with a photosensitive skin rash involving his face
and upper trunk and inflammatory type symmetrical
polyarthritis involving small and large joints of 3 months
duration. On examination the r ew e r em u l t i p l em a c u l o -
papular cutaneous lesions with hyperpigmented borders
and hypopigmented central region with scarring distrib-
uted over the face, upper chest and upper back (Figure
1). Laboratory investigations revealed a normal complete
blood count and urinalysis. His ESR was 110 mm/1
st
hour while C-reactive protein (CRP) was within normal
range. Biopsy of his of his skin lesions showed an
atrophic epidermis with focal basal cell degeneration,
follicular plugging and scanty lymphocytic infiltration of
dermis favoring a diagnosis of lupus erythematosus.
Immunological investigations showed a positive ANA
(titre > 1:400) and anti-ds-DNA as well reduced levels
of C3 and C4. VDRL was positive but subsequent
TPHA was negative. Antiphospholipid antibodies were
negative. A diagnosis of Systemic Lupus Erythematosus
(SLE) was made based on demonstration of 5 American
Rheumatological Association criteria [8] and he was
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chloroquine 200 mg twice daily. He responded to the
treatment over the next few weeks as evident by the rise
in serum albumin subsequently (Figure 2) along with
healing of the skin rash and reduced oedema.
3 years prior to his current admission he was investi-
gated extensively for generalized oedema, of 6 months
duration and found to have severe hypoalbuminaemia
without evidence of any renal or hepatic cause. He did
not have significant diarrhea or steatorrhea but com-
plained of vague left sided abdominal discomfort. Physi-
cal examination was unremarkable except for facial and
mild bilateral pedal oedema. Laboratory investigations at
that time were as follows: haemoglobin, 12.1 g/dl; white
cell count 6.5 k/mm3 with normal differential count;
platelet count 235 k/mm3; urinalysis, trace of albumin
with no active sediments; 24 hour urinary protein excre-
tion 0.12 g; serum creatinine 82 micromol/l; serum
albumin 19 g/l; serum globulin 38 g/l; AST 28 u/l; ALT
30 u/l; ALP; ESR 115 mm/1
st hour; CRP 17 mg/l; serum
total cholesterol 277 mg/dl, triglyceride 157 mg/dl, LDL
cholesterol 196 mg/dl, HDL cholesterol 47 mg/dl; serum
immunoglobulin assay was low normal for IgG, IgM and
IgA. Ultrasonic scan of abdomen showed normal liver
architecture and no evidence of portal hypertension.
Percutaneous liver biopsy was histologically
Figure 1 Discoid rash on patient’s neck and chest.
Figure 2 Serum protein timeline depicting rise of serum albumin following treatment with steroids commenced in March 2010.
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diac chambers and function. Barium studies of small
bowel, upper and lower gastrointestinal endoscopies did
not show significant pathology. Duodenal and distal ileal
biopsies were done and showed evidence of lymphan-
giectasia without evidence of significant inflammatory
cell infiltrate. A technetium labeled lymphangioscintigra-
phy of both lower limbs and abdomen did not show any
lymphatic obstruction. A diagnosis of primary lymphan-
giectasia causing protein losing enteropathy was made
and he was symptomatically treated with diuretics for
facial and pedal oedema. Six months later, he had a non
ST elevation myocardial infarction complicated by a
supra ventricular tachycardia. As coronary angiography
at that stage showed evidence of extensive triple vessel
disease he subsequently underwent Coronary artery
bypass grafting. He did not have vascular risk factors
except for dyslipidaemia such as diabetes mellitus,
hypertension or family history of premature athero-
sclerosis and was a non-smoker. He was followed up
regularly and had a stable health until his current
presentation.
Discussion
Although an association between systemic lupus erythe-
matosus and protein losing enteropathy has been recog-
nized, there have been less than less than 150 cases
documented in world literature [9]. There are no docu-
mented cases of such an association in Sri Lankan litera-
ture. Systemic lupus erythematosus presenting as protein
losing enteropathy has been reported even less
commonly.
Multiple theories as to the pathophysiology of the
association between the two entities exist, such as
intestinal vasculitis, mucosal erosions or lymphangiecta-
sia, but each case seems to have its separate mechanism
of protein loss. We discovered that the mechanism in
our patient is through intestinal lymphangiectasia, as
has been published in 2 other cases in world literature
[10].
The diagnosis of protein-losing enteropathy can be
successfully made by radioisotope studies or 24-hour
stool 1-antitrypsin clearance. Unfortunately these 2
investigations were not at our disposal at the National
Hospital of Sri Lanka to make a concrete diagnosis. We
however could confidently conclude that PLE was
responsible for the hypoalbuminaema as all other causes
such as urinary loss, underproduction due to liver dis-
ease and malnutrition were excluded. The association
between SLE and PLE was derived mainly from the
response of serum albumin following steroid treatment
since March 2010 as shown in Figure 2. Other differen-
tials for PLE such as Whipple’s Disease (Non-suggestive
duodenal biopsy), Crohn’s disease (Negative clinical
history and duodenal biopsy) and Primary Lymphangiec-
tasia (Dramatic response to steroids) were excluded.
At the time of publishing, we have planned on per-
forming a repeat endoscopy and re-biopsy to identify
the histological response to treatment. Chase et al in
1982, were the first to postulate that intestinal lymphan-
giectasia in SLE was steroid responsive [11] as was
shown in our case 18 years later. It is worthwhile noting
that endoscopy is usually unhelpful in the diagnosis, as
50% of SLE-related PLE patients present with nonspeci-
fic intestinal wall edema and 10% of patients have no
abnormalities under endoscopy examination [9]. The
expected histological finding are lymphangiectasia, ede-
matous villi and non-specific inflammation, but it can
also be normal because of the inaccessibility of the
involved area [1].
Although PLE associated with intestinal lymphangiec-
tasia is associated with other phenomena such as lym-
phopaenia and hypolipidaemia apart from
hypoalbuminaemia, it was not shown in our patient.
The very high ESR with relatively normal CRP is quite
characteristic of SLE without serositis [12].
It is also interesting to note the considerable lag per-
iod between his initial presentation with PLE which was
followed 3 years later with the characteristic discoid
rash of SLE. It is worth mentioning that SLE was not
considered as a possible diagnosis at the initial stage as
he did not fulfill the necessary criteria. We do not routi-
nely perform ANA testing of patients with high ESR at
our institution.
It would be natural to assume that the acute coronary
syndrome suffered by the patient might be due
thrombo-embolism secondary to SLE with possible sec-
ondary anti-phospholipid syndrome. This theory was
dispelled however from the coronary angiography find-
ing of extensive atherosclerotic disease.
A recent systemic review by Al-Mogairen [13]
describes over a hundred patients with SLE and PLE of
whom the majority of Asian in origin. Unfortunately he
does not specify the Asians to be from either South or
South-East Asian background. SLE with associated PLE
i sq u i t er a r ei nt h eI n d i a nS u b c o n t i n e n tw h i c hh a sa
population of over 1.5 billion as evident by the limited
number of published case reports.
Conclusion
Protein losing enteropathy is a diagnosis of exclusion in
resource limited centres in the world. Systemic lupus
erythematosus should be considered in the differential
diagnosis of protein losing enteropathy. Intestinal lym-
phangiectasia should also be recognized as a possible
pathophysiological mechani s m .T h ef a c tt h a tt h i sp h e -
nomenon is steroid sensitive in most instances such as
in our case should be a relief to both clinicians and
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in a highly populated territory such as the Indian Sub-
Continent makes this case report intriguing.
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for publication of this case report and any accompany-
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